Migration, public health and compulsory screening for TB and HIV Richard Coker 8 th October 2003.

Slides:



Advertisements
Similar presentations
State of the Art The Status and Trends of HIV/AIDS Epidemics
Advertisements

Abortion Worldwide: A Decade of Uneven Progress
Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
HIV/AIDS Weakens the Immune System
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
For primary and secondary care settings
Access to HIV treatment Issues of working with HIV positive refugees and asylum seekers Linda McDonald MA MSc RN.
Of South Africa DOTS WORKS VWSA WORKPLACE PROGRAM.
Trends in fungal disease in the UK Theresa Lamagni Healthcare-Associated Infection & Antimicrobial Resistance Department HPA Centre for Infections.
HIV/AIDS and Women: An Overview Global HIV/AIDS and Women: Current Challenges and Opportunities Briefing, Rayburn House Office Building Jen Kates, PhD.
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Adapting National HIV Strategy to a Socially and Geographically Concentrated Epidemic: The Case of Papua New Guinea Dr. Moale Kariko PNG.
The Policy Implications of Emigration from the UK: Target and Uncertainty Dr Carlos Vargas-silva Emigration – Don’t leave me this way? British Society.
1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)
GAP Report 2014 Sex workers People left behind: Sex workers Link with the pdf, Sex workers.
HIV AND AGING Carol Nawina NYIRENDA PAN AFRICAN POSITIVE WOMENS COALITION (PAPWC) COALITION OF ZAMBIAN WOMEN LIVING WITH HIV.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Criminal Prosecution for HIV Transmission. With ENORMOUS thanks to: Yusef Azad – NAT Lisa Power - THT.
Tuberculosis in the UK 2013 report
Directions in national immigrant health National Symposium on Immigrant Health Citizenship and Immigration Canada Citoyenneté et Immigration Canada Medical.
Rhon Reynolds Head of Policy and Acting CEO, African HIV Policy Network AIDS Mexico City 3-8 August XVII International AIDS Conference 5.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Ivan Cruickshank Caribbean Vulnerable Communities Coalition.
Asylum Seekers Facts and figures on the current debate.
New Entrant TB Screening Dr. John P. Watson Consultant Respiratory Physician.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
HIV and Indigenous Peoples in Aotearoa, Australia and Canada Clive Aspin.
Dr Elhadji MBAYE Science po Grenoble/ IRD/ U. Montreal
Africans and HIV in the UK: an epidemiological perspective Nov 2006 Tim Chadborn On behalf of the HIV Reporting Section with special thanks to Julia Abernethy.
HIV and migration in Western industrialized countries: Common challenges and future directions On behalf of CDC, PHAC, ECDC and IOM Marita van de Laar,
Immigration Removal Centres and HIV Joe Murray Policy Officer National AIDS Trust.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Developing world epidemics in the developed world: HIV/AIDS among Caribbean people in the UK, US and the Caribbean Kevin Fenton, M.D., Ph.D. Director National.
1 PHSKC 4/01 Epidemiology of HIV/AIDS Seattle-King County, WA HIV/AIDS Epidemiology Program Public Health - Seattle & King Co. (206) On the web.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
100 years of living science Page 1 BSc in Global Health Paolo Vineis Helen Ward Peter Piot.
HIV and African M S M in England: A new wave of Challenge. Presented by Adebisi Alimi.
Sexual transmission of HIV amongst migrant populations in Europe: managing change in surveillance, interventions and prevention V.Delpech and Teymur Noori.
UNAIDS: PANAMA CITY, PANAMA
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Kow-Tong Chen, M.D., Ph.D., Hsiao-Ling Chang, Ph.D., Chu-Tzu Chen, M.P.H., and Ying-An Chen, M.P.H. Volume 23, Number 3, 2009 AIDS PATIENT CARE and STDs.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
The case for HIV testing A presentation for the clinical team in your practice.
HIV vulnerabilities of sex workers in Europe
Mary Tooley Consultant Nurse – Public Health IGRA screening in primary care – ’The Sandwell Experience’
KEY ISSUES FACING LATINO COMMUNITY IN ADDRESSING HIV/AIDS AN OVERVIEW.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
HIV/AIDS Summary of Questions. What is HIV? Human immunodeficiency virus (remember, no official scientific name for viruses) Human immunodeficiency virus.
HIV and STI Department The case for HIV testing A presentation for the clinical team in your practice.
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
Africans and HIV in the UK: an epidemiological perspective May 2006 Valerie Delpech On behalf of the HIV Reporting Section with special thanks to Julia.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
2013 HIV/AIDS Surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Epidemiology of STIs (including HIV and HBV infections) in undocumented migrants in Europe: what do we know? Andrew Amato, Head of HIV/STI/Hepatitis Programme,
HIV testing guidance: know, treat, prevent
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Global epidemiology of injecting drug use
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV/AIDS Surveillance in Europe 2011
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Migrants Dr Julia del Amo National Center for Epidemiology
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Communicable Disease Surveillance Centre, London
Presentation transcript:

Migration, public health and compulsory screening for TB and HIV Richard Coker 8 th October 2003

The purpose of screening Epidemiological trends What risk? Effective tools, effective policies? Will compulsion improve effectiveness? Conclusions

On the agenda Read This And Get Angry Sun, 29 Jan 2003 The Secret Threat to British Lives The Spectator, 25 Jan 2003 No System to Abuse: immigration and health care in the UK Centre for Policy Studies, May 2003, Before Its Too Late: A New Agenda for Public Health Conservative Party consultation paper, August 2003 Inquiry into Imported Infections Cabinet Office, announced Jan 2003 Migration and HIV: Improving Lives in Britain All- Party Parliamentary Group on AIDS, July 2003

Before Its Too Late Advocates 3 tests before permission given to remain in the UK: 1.They must not pose a risk of transmitting an infectious disease to the public 2.They must not create undue demand on restricted health resources 3.They must not create a long-term drain on the public purse those entering the UK through the immigration system would require [sic] to have such tests at the point of application and to pay for them, whilst those seeking asylum would be detained until it was clear the criteria had been met

Purpose of Screening To identify individuals with infection in order to provide the appropriate care and treatment for that individual To prevent public health consequences of undetected infectious disease through case detection

Tuberculosis: key national facts (1) Tuberculosis case reports, by geographic origin, England and Wales, Since 1988, number of cases of TB and the rate has increased Proportion born abroad has also increased Poverty, overcrowding, exposure risk Treatment of TB costs approx. £6,000

Tuberculosis: key national facts (2) Tuberculosis case reports born abroad by time since entry into the UK Half of those born abroad who develop TB do so within 5 years Perhaps 0.3% of asylum seekers have TB at port screening, and of these only ¼ have infectious disease Number of cases detected through Heathrow represents less than 0.5% of cases Asylum seekers represent a fraction of immigrants – but it is principally asylum seekers who are currently screened In one study, screening systems failed to identify 60% of new immigrants with TB

Immigrant-associated TB: a public health threat? Evidence from many sources –US states with high levels of TB in foreign-born persons do not correspondingly have high rates in those born in US –From DNA finger-printing, most TB in London is reactivation –From Denmark a study showed that transmission between immigrants and native-born Danes almost non-existent Correlation between State-Specific Tuberculosis Case Rates for Foreign-Born Persons and U.S.-Born Persons in the United States, 1986 to 1993

HIV: key facts (1) Heterosexually acquired infection by sub-category of heterosexual exposure At end 2001, estimated 41,000 adults living with HIV in the UK Proportion infected through heterosexual sex is increasing Most heterosexually- acquired HIV is acquired or linked to abroad (71% to Africa) Sex between men & women (total)No evidence "high risk" partner: Exposure abroad No evidence "high risk" partner: Exposure UKExposure to "high risk" partner Year of diagnosis Number of diagnoses

Immigrant-associated HIV: a public health threat? Of 2,046 individuals infected in the UK, at least half were infected through heterosexual sex with someone originating from outside Europe London-based study suggested that 9% of heterosexually-acquired HIV in black Africans acquired in UK Migrants returning Potentially many people unaware and unsuspecting of their HIV status (black Africans > white)

2 cardinal questions: Does screening detect those with the condition? Will screening assist in achieving the desired public health objective?

Does screening detect those with the condition? HIV: it depends TB: it depends

Screening for HIV The tests are sensitive and specific But focused screening may assume –That immigrants from high prevalence countries have prevalence rates that reflect donor countries –That populations freely able to move dont pose a threat (new eastern European border) –That those not screened will be served by other systems (illegal immigrants, transient populations)

X-rays to detect TB Theoretical population with prevalence rate of 600/100,000 10,000 immigrants screened Theoretical population with prevalence rate of 40/100,000 10,000 immigrants screened Expected number of cases of disease 604 Number of cases of TB detected through X- ray screening 453 Number of cases of TB missed through X- ray screening 151 Number of people without TB, but classified as having TB 100 Proportion of people identified with TB who actually have it 31%3%

X-ray at screening and 6 months later, Swiss asylum seeker

Will screening assist in achieving the desired public health objective? TB –Evidence is lacking No clinical trials DH-funded transmission and economic model due to report shortly HIV –Screening only confers public health benefit if effective action follows –Evidence is lacking

Refusing entry to HIV-infected immigrants –May reduce burden of disease, costs, and future transmission –May stigmatise, ensure evasive practices –How often should people be screened? –Illegal in asylum seekers Should they be isolated? For how long? Does the risk arise because of status or behaviour?

Coercion and protection of the public health

Long historical tradition, with little evidence of benefit of detention or compulsory screening May show that the government is seen to be taking firm, decisive action and the epidemic appears to be under control (Panos Institute) Coercive measures may be counterproductive

Public Health Authorities Bear the Burden of Justification

Conclusion (1) Increases in HIV and TB rates are linked to immigration, but have been difficult to quantify These changes may reflect, in part, global trends Most TB occurs in people after entry There is probably a substantial population of HIV- infected people in the UK unaware of their status who pose a public health challenge

Conclusion (2) Evidence-base to support TB screening of immigrants is weak Screening tests for TB lack validity Screening tests for HIV are reliable Evidence is lacking regarding screening immigrants for HIV Significant ethical, moral, legal and practical issues are raised with coercive measures Coercive screening practices may result in unforeseen perverse consequences

Purpose of Screening To identify individuals with infection in order to provide the appropriate care and treatment for that individual To prevent public health consequences of undetected infectious disease through case detection